CCP
EMN icon

Corient Capital Partners’s Eastman Chemical EMN Stock Holding History

Corient Capital Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2M Hold
22,285
– – 0.15% 122
2022
Q2 		$2M Buy
22,285
+482
+2% +$49.9K 0.15% 130
2022
Q1 		$2.44M Buy
21,803
+213
+1% +$25K 0.16% 135
2021
Q4 		$2.61M Sell
21,590
-1,613
-7% -$179K 0.17% 125
2021
Q3 		$2.34M Buy
23,203
+1,105
+5% +$122K 0.17% 128
2021
Q2 		$2.58M Buy
22,098
+631
+3% +$75.8K 0.19% 115
2021
Q1 		$2.36M Sell
21,467
-962
-4% -$104K 0.2% 105
2020
Q4 		$2.25M Sell
22,429
-2,747
-11% -$255K 0.22% 101
2020
Q3 		$1.97M Sell
25,176
-1,632
-6% -$123K 0.23% 104
2020
Q2 		$1.87M Buy
26,808
+2,369
+10% +$149K 0.23% 101
2020
Q1 		$1.14M Buy
24,439
+8,408
+52% +$540K 0.18% 114
2019
Q4 		$1.27M Buy
16,031
+327
+2% +$25.1K 0.16% 144
2019
Q3 		$1.16M Buy
15,704
+1,076
+7% +$77.2K 0.16% 144
2019
Q2 		$1.14M Buy
14,628
+358
+3% +$27.2K 0.17% 155
2019
Q1 		$1.08M Buy
14,270
+2,585
+22% +$205K 0.18% 157
2018
Q4 		$855K Buy
11,685
+6,873
+143% +$548K 0.15% 164
2018
Q3 		$461K Hold
4,812
– – 0.08% 202
2018
Q2 		$481K Hold
4,812
– – 0.08% 193
2018
Q1 		$508K Sell
4,812
-118
-2% -$11.9K 0.09% 169
2017
Q4 		$457K Hold
4,930
– – 0.08% 192
2017
Q3 		$446K Sell
4,930
-630
-11% -$53.6K 0.08% 188
2017
Q2 		$467K Sell
5,560
-4
-0.1% -$322 0.07% 212
2017
Q1 		$450K Sell
5,564
-351
-6% -$27.6K 0.07% 213
2016
Q4 		$445K Sell
5,915
-304
-5% -$22K 0.08% 212
2016
Q3 		$421K Buy
+6,219
New +$417K 0.08% 214

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corient Capital Partners's EMN Position: Q3 2022 in Review

Corient Capital Partners held its Eastman Chemical (EMN) position steady in Q3 2022 at 22,285 shares worth $2M. The position accounts for 0.15% of the portfolio, ranked #122.

Corient Capital Partners first reported a position in EMN in Q3 2016 and has held it in 25 quarters since. The position peaked at $2.61M in Q4 2021. 656 funds tracked by Wall St. Rank hold EMN as of Q3 2022.

  • Corient Capital Partners held 22,285 shares of Eastman Chemical worth $2M as of Q3 2022.
  • Corient Capital Partners left its Eastman Chemical share count unchanged in Q3 2022.
  • Eastman Chemical made up 0.15% of Corient Capital Partners's portfolio in Q3 2022, its #122 holding.
  • Corient Capital Partners first reported a position in Eastman Chemical in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's Eastman Chemical position peaked at $2.61M in Q4 2021.
  • 656 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.